Case Report: Pelvic abscess formation secondary to the use of commercial hemostatic topical agent in an immunocompromised patient?
<p>Various hemostatic agents are currently available for routine laparoscopic procedures, avoiding thermal lesions due to energy devices and the complexity of intracorporeal sutures, however, evidence of complications in immunocompromised patients is still lacking. We present the case of a sev...
Saved in:
Main Authors: | Mónica Monzón-Vargas (Author), Yuliana Gómez- Meraz (Author), Rodrigo Ayala-Yáñez (Author) |
---|---|
Format: | Book |
Published: |
Journal of Gynecological Research and Obstetrics - Peertechz Publications,
2017-07-03.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluating the risk of post-operative abscess formation following use of hemostatic agents at time of hysterectomy
by: Megan Howard, et al.
Published: (2022) -
Lung abscess in immunocompromised
by: Teresa Margarida Dias Moreira, et al.
Published: (2020) -
Achieving hemostasis in dermatology-Part II: Topical hemostatic agents
by: Jaimie B Glick, et al.
Published: (2013) -
Medicinal Plants as Potential Hemostatic Agents
by: Fatemeh Ebrahimi, et al.
Published: (2020) -
Pelvic floor abscess secondary to gossypiboma following a total Prolift procedure
by: Chung-Yu Chang, et al.
Published: (2012)